Northeast Pharmaceutical Group Co., Ltd., Devixi DOVC, a well-known vitamin brand, a high-tech enterprise, and a large-scale comprehensive pharmaceutical enterprise focusing on chemical APIs
【Drug Name】
Generic name: Chewable vitamin C
Product Name: Vitamin C Chewable Tablets (Devhi)
拼音全码：WeiShengSuCJuJiaoPian(DeWeiXi)
【Main ingredients】This product is vitamin C.
【Properties】This product is a chewable tablet.
【Indications/Indications】It is used for the prevention of scurvy, and can also be used for the adjuvant treatment of various acute and chronic infectious diseases and purpura.
[Specification and model] 200mg*36s
【Usage and Dosage】Swallow after chewing, the usual amount is 1 tablet at a time, 3 times a day.
【Adverse reactions】
1. Long-term use of 2~3 grams per day can cause scurvy after drug withdrawal, so it is advisable to gradually reduce the dose and stop the drug.
2. Long-term application of a large amount of vitamin C can cause urate, cysteine or oxalate stones.
3. Overdose (daily dosage of more than 1 gram) can cause diarrhea, red and bright skin, headache, frequent urination (daily dosage of more than 600mg), nausea and vomiting, and stomach cramps.
4. Excessive use of chewable vitamin C tablets can cause damage to tooth enamel.
[Contraindications] are not yet clear.
【Precautions】
1. It is not advisable to take this product in excess for a long time, otherwise, sudden discontinuation of the drug may cause symptoms of scurvy.
2. This product can pass through the placenta and secrete into milk. When pregnant women take too much, it can induce the production of scurvy in newborns
3. The following conditions should be used with caution: (1) cysteinuria (2) gout (3) hyperoxaluria (4) oxalate deposition (5) urate nephrolithiasis (6) glucose-6-phosphate dehydrogenase deficiency (7) hemochromatosis (8) sideroblastic anemia or thalassemia (9) sickle cell anemia (10) diabetes mellitus (due to vitamin C interference with blood glucose quantification).
4. If you overdose or have serious adverse reactions, you should seek medical attention immediately.
5. Those who are allergic to this product are prohibited, and those with allergies should use with caution.
6. It is forbidden to use this product when its properties change.
7. Keep this product out of reach of children.
8. If you are using other medicines, please consult a physician or pharmacist before using this product.
[Pediatric medication] is not clear.
[Medication for elderly patients] is not clear.
[Medication for pregnant and lactating women] is not clear.
【Drug Interactions】 1. Oral administration of high-dose vitamin C can interfere with the anticoagulant effect of anticoagulants. 2. Combined with barbiturate or primidone, it can promote the increase of vitamin C excretion. 3. Cellulose sodium phosphate can promote the metabolism of vitamin C to oxalate. 4. Long-term or large application of vitamin C can interfere with the effect of disulfiram on ethanol. 5. Salicylic acid can increase the excretion of vitamin C. 6. Drug interactions may occur if used at the same time with other drugs, please consult a physician or pharmacist for details.
[Drug overdose] is not known.
【Pharmacology and Toxicology】This product is involved in the formation of antibodies and collagen in the body, tissue repair (including some redox effects), the metabolism of phenylalanine, tyrosine, folic acid, the utilization of iron and carbohydrates, the synthesis of fat and protein, as well as the maintenance of immune function, the hydroxylation of serotonin, the integrity of blood vessels, and the promotion of non-heme iron absorption.
[Pharmacokinetics] is not clear.
【Storage】Sealed.
[Packing] 200mg*36s/box.
Expiration date: 24 months
【Approval number】National medicine quasi-word H21022599
【Manufacturer】Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd
Northeast Pharmaceutical Group Co., Ltd., referred to as "Northeast Pharmaceutical", is a large-scale comprehensive pharmaceutical enterprise focusing on chemical raw materials, biological fermentation, Chinese and Western medicine preparations and microecological preparations. The company's stock is listed on the Shenzhen Stock Exchange, stock code: 000597.
Northeast Pharmaceutical Co., Ltd. was formally established in June 1993 and is one of the first batch of pilot joint-stock enterprises in Shenyang, one of the top 500 enterprises in China in 2004 and one of the top 500 manufacturing enterprises in China in 2005. In 2004, "Northeast Medicine" was rated as one of China's 500 most valuable brands by the World Economic Forum and the World Brand Lab in Davos, Switzerland. In 2005, it was rated as one of the top ten pharmaceutical brands in China by the World Brand Laboratory, and ranked 247th in the list of "China's 500 Most Valuable Brands" in 2006 with a value of 2.613 billion yuan. On January 23, 2006, Northeast Pharmaceutical, as the first pilot enterprise of equity division reform in Shenyang, successfully carried out the equity division reform. In addition, the "Northeast" brand was identified by the Ministry of Commerce as the key cultivation and development of export brands in 2005-2006. The company has also been rated as a national "20 consecutive years of contract-abiding and trustworthy enterprise", Liaoning Province "high-tech enterprise", special prize of foreign trade export special contribution award, excellent tax enterprise and many other honors.
The company mainly produces more than 800 kinds of raw materials and preparation products, such as antibiotics, vitamins, cardiovascular and cerebrovascular, digestive system, antiviral, natural medicine, anti-AIDS, narcotic psychotropic drugs, anti-tuberculosis drugs, family planning drugs, cosmetics, etc.
